Skip to main content
. 2022 Feb 23;30(5):1801–1809. doi: 10.1016/j.ymthe.2022.02.022

Figure 1.

Figure 1

Medicinal product value chain from discovery to availability and use for health impact, providing examples of inefficiencies of the current competitive, supply-driven, fragmented R&D ecosystem specifically for epidemic preparedness and response